Filing Details

Accession Number:
0001209191-23-025464
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-24 18:09:25
Reporting Period:
2023-04-20
Accepted Time:
2023-04-24 18:09:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1503802 Karyopharm Therapeutics Inc. KPTI Pharmaceutical Preparations (2834) 263931704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1825322 Reshma Rangwala C/O Karyopharm Therapeutics Inc.
85 Wells Avenue
Newton MA 02459
Evp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-04-20 115 $4.03 164,885 No 4 S Direct
Common Stock Disposition 2023-04-20 6,655 $4.05 158,230 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.